CompletedNCT05521932
Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair
Studying Asherman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Principal Investigator
- Ruijin Wu, M.D.Women's Hospital, College of Medicine Zhejiang University
- Intervention
- endometrium collected(other)
- Enrollment
- 6 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2022 – 2024
Study locations (1)
- Women's Hospital, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05521932 on ClinicalTrials.govOther trials for Asherman syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT05343572Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal EndometriumHugh Taylor
- ENROLLING BY INVITATIONNANCT06608407Platelet Rich Plasma in the Prevention of Adhesion ReformationFu Xing Hospital, Capital Medical University
- ACTIVE NOT RECRUITINGNANCT04963179PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.Womed
- RECRUITINGPHASE4NCT04671914Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.Institute for the Care of Mother and Child, Prague, Czech Republic